Efficacy of “Intense Pulsed Light versus Benzoyl Peroxide 2.5% Gel” in Treatment of Mild to Moderate Facial Acne Vulgaris in Iraqi patients Efficacy of “Intense Pulsed Light versus Benzoyl Peroxide 2.5% Gel” in Treatment of Mild to Moderate Facial Acne Vulgaris in Iraqi patients

Main Article Content

Mohammad J. Al Abdullah
Yasameen Gheni Mahdi

Keywords

Pulsed light, subjective, objective, clinical trial, facial acne, vulgaris, Iraqi patients

Abstract

The Intense pulse light (IPL)  therapy has   three  mechanisms  of  action  in   acne   vulgaris; photo-chemical,  photo-immunological  and  photo-thermal. In this clinical trial forty seven patients with facial inflammatory acne lesion , their ages ranged from 15 to 40 years were  enrolled. Patients included in two groups, 20 patients in group A  treated with IPL for 3 sessions; 3 weeks apart, and  27 patients in group B treated with BPO 2.5% gel daily at night for 9 weeks. Follow up at 3 weeks after the end treatment. The effect of treatment  was evaluated objectively  according to  total lesion counting  and  digital  photographic  assessment   and  subjectively  according  to the  patients satisfaction. IPL is effective and well tolerated method in the   treatment    of    inflammatory  facial  acne  like  BPO. Therefore, the IPL can be used as standard therapy for Inflammatory acne vulgaris.

Abstract 75 | PDF Downloads 63 XML Downloads 14 HTML Downloads 16 word Downloads 27

References

1. Nair DG, et al. Acne vulgaris and quality of life among adults in South India. Indian J Dermatol. 2015;60(1):33.
2. Alison M. Layton, E. Anne Eady and Christos C. Zouboulis. Acne . In:. Christopher E. M. Griffiths, Jonathan Barker , Tanya Bleiker . Robert Chalmers & Daniel Creamer (eds). Rook's Text Book of Dermatology, 9th Edition , Blackwell Scientific Publication 2016; 90:1-16.
3. Lynn DD, Umari T, Dunnick CA, Dellavalle RP. The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther. 2016;7:13-25.
4. Goh C., Cheng C., Agak G., Zaenglein AL, Graber EM, Thiboutot DM, & Kim J. Acneiform disorders. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis MJ, Mcmichael PJ, Orringer MS (eds). Fitzpatrick’s detmatology, 9th Ed. McGraw Hill 2019;1,78:1391-1407.
5. Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168:474-485.
6. Bataille V, et al.The infuence of genetics and environmental factors in the pathogenesis of acne: A twin study of acne in women. J Invest Dermatol. 2002;119:1317-1322.
7. Zaenglein AL, Thiboutot DM. Acne vulgaris. In: Bolognia JL, Schaffer JV, Cerroni L(eds.). Dermatology, 4th edition. Mosby Elsevier 2018;1,36:588-601.
8. Jeremy AHT, Holland DB, Roberts SG , et al. informatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121:20–7.16.
9. Habif TP. Acne and related disorder. In clinical Dermatology: Acolor Guide to Diagnosis and Therapy, 5th ed. Edinburgh, UK, Mosby 2010; 7: 217–247.
10. Cantatore-Francis JL, Glick SA. Childhood acne: evaluation and management. Dermatol Ther. 2006;19:202-209.
11. Chen W, Thiboutot D, Zouboulis CC. Cutaneous androgen metabolism: basic research and clinical perspectives. Journal of investigative dermatology, 2002;119(5):992-1007.
12. Lai JJ, et al. The role of androgen and androgen receptor in skin-related disorders. Archives of dermatological research, 2012;304(7):499-510.
13. Abdel-Fattah NS, Shaheen MA, Ebrahim AA, El Okda ES. Tissue and blood superoxide dismutase activities  and  malondialdehyde levels in different clinical severities of acne vulgaris. Br J Dermatol. 2008;159:1086–91.21.
14. Tanghetti EA. The role of inflammation in the pathology of acne. The Journal of clinical and aesthetic dermatology 2013; 6(9): 27.
15. Chronnell CM, Ghali LR, Ali RS, et al. Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J Invest Dermatol. 2001;117:1120–1125.
16. Nakatsuji T, Kao MC, Zhang L, et al. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression. J Invest Dermatol. 2010;130:985–994.
17. Nagy I, Pivarcsi A, Koreck A, et al. Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J Invest Dermatol. 2005;124:931–938.
18. Segre JA. What does it take to satisfy Koch’s postulates two centuries later? Microbial genomics and P. acnes. J Invest Dermatol. 2013;133(9):2141–2.23.
19. Lheure C,  Grange  PA,  et al. TLR-2  recognizes Propionibacterium  acnes CAMP factor 1 from  highly inflammatory strains. PLoS ONE 2016;11:e0167237.26.
20. Kim J, Ochoa MT, Krutzik SR, et  al.  Activation of  toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 2002;169:1535–41.27.
21. Jalian HR, Liu PT, Kanchanapoomi M, et al. All-trans retinoic acid shifts Propionibacterium acnes-induced matrix degradation expression  profile  toward  matrix preservation in human monocytes. J Invest Dermatol. 2008;128:2777–82.28.
22. Qin  M, Pirouz A, Kim MH,  et al.  P.  acnes Induces IL-1β secretion via the NLRP3  inflammasome in human monocytes. J Invest Dermatol. 2014;134:381–8.30.
23. Kistowska M, Meier B, et al. P.acnes promotes Th17 and Th17/Th1 responses in acne patients.  J  Invest Dermatol. 2015;135:110–18.31.
24. Kumaresan M, Srinivas C R. Efficacy of IPL in treatment of acne vulgaris: Comparison of single-and burst-pulse mode in IPL. Indian journal of dermatology 2010; 55(4): 370-2.
25. Liu PT, Phan J, et al. CD209(+) macrophages mediate host defense against P. acnes. J Immunol 2008;180:4919–23.31a.